Es gab 50 kürzliche Insider-Transaktionen für NGM Biopharmaceuticals, Inc. (NGM), darunter 26 Käufe und 24 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $5.19M und die gesamten Insider-Verkäufe auf $20.6M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Goeddel David V, Rieflin William Jl, Perlmutter Roger M. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — NGM
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2024-04-05 |
Goeddel David V |
10 Percent Owner |
Aktienrückgabe |
16,806 |
$20.37 |
$342.34K |
- |
| 2024-04-05 |
Rieflin William Jl |
Director |
Aktienrückgabe |
225,000 |
$8.14 |
$1.83M |
- |
| 2024-04-05 |
Perlmutter Roger M |
Director |
Aktienrückgabe |
24,222 |
$13.35 |
$323.36K |
- |
| 2024-04-05 |
Column Group L P |
10 Percent Owner |
Aktienrückgabe |
44,000 |
- |
- |
- |
| 2024-04-05 |
Pierce Valerie L |
See Remarks |
Aktienrückgabe |
147,000 |
$4.36 |
$640.92K |
- |
| 2024-04-05 |
Viret Jean-frederic |
Chief Financial Officer |
Aktienrückgabe |
450,000 |
$0.77 |
$346.5K |
- |
| 2024-04-05 |
Lieu Hsiao D |
Chief Medical Officer |
Aktienrückgabe |
159,000 |
$4.36 |
$693.24K |
- |
| 2024-04-05 |
Hooper Suzanne Sawochka |
Director |
Aktienrückgabe |
25,000 |
$12.06 |
$301.5K |
- |
| 2024-04-05 |
Guyer Shelly D |
Director |
Aktienrückgabe |
16,806 |
$20.37 |
$342.34K |
- |
| 2024-04-05 |
Column Group Gp, Lp |
10 Percent Owner |
Aktienrückgabe |
44,000 |
- |
- |
- |
| 2024-04-05 |
Woodhouse David J |
Chief Executive Officer |
Aktienrückgabe |
500,000 |
$4.36 |
$2.18M |
- |
| 2024-04-05 |
Ho Carole |
Director |
Aktienrückgabe |
39,515 |
$20.66 |
$816.38K |
- |
| 2024-04-05 |
Tcg Opportunity Iii Gp, Llc |
10 Percent Owner |
Aktienrückgabe |
44,000 |
- |
- |
- |
| 2024-04-05 |
Perlich Irene |
Principal Accounting Officer |
Aktienrückgabe |
20,000 |
$1.07 |
$21.4K |
- |
| 2024-01-16 |
Pierce Valerie L |
SVP, Gc & Cco |
RSU-Steuereinbehalt |
5,021 |
$1.34 |
$6.73K |
55,374 |
| 2024-01-16 |
Lieu Hsiao D |
EVP, Chief Medical Officer |
RSU-Steuereinbehalt |
5,430 |
$1.34 |
$7.28K |
54,254 |
| 2024-01-16 |
Woodhouse David J |
Chief Executive Officer |
RSU-Steuereinbehalt |
13,032 |
$1.34 |
$17.46K |
131,822 |
| 2024-01-16 |
Perlich Irene |
Principal Accounting Officer |
RSU-Steuereinbehalt |
1,025 |
$1.34 |
$1.37K |
8,975 |
| 2023-12-01 |
Viret Jean-frederic |
Chief Financial Officer |
RSU-Zuteilung |
450,000 |
$0.77 |
$346.5K |
450,000 |
| 2023-11-16 |
Goeddel David V |
10 Percent Owner |
Informierter Kauf |
1,460 |
$0.62 |
$906.81 |
134,180 |
| 2023-11-16 |
Column Group L P |
10 Percent Owner |
Informierter Kauf |
5,840 |
$0.62 |
$3.63K |
949,862 |
| 2023-11-15 |
Goeddel David V |
10 Percent Owner |
Informierter Kauf |
2,720 |
$0.71 |
$1.92K |
132,720 |
| 2023-11-15 |
Column Group L P |
10 Percent Owner |
Informierter Kauf |
16,791 |
$0.71 |
$11.88K |
944,022 |
| 2023-11-06 |
Pierce Valerie L |
SVP, Gc & Cco |
Aktienrückgabe |
150,000 |
$15.20 |
$2.28M |
- |
| 2023-11-06 |
Lieu Hsiao D |
EVP, Chief Medical Officer |
Aktienrückgabe |
100,000 |
$31.93 |
$3.19M |
- |
| 2023-11-06 |
Woodhouse David J |
Chief Executive Officer |
Aktienrückgabe |
400,000 |
$16.47 |
$6.59M |
- |
| 2023-11-06 |
Perlich Irene |
Principal Accounting Officer |
Aktienrückgabe |
35,000 |
$15.20 |
$532K |
- |
| 2023-11-03 |
Viret Jean-frederic |
Chief Financial Officer |
Veräußerung |
- |
- |
- |
38 |
| 2023-09-15 |
Perlich Irene |
Principal Accounting Officer |
Veräußerung |
30,000 |
$4.36 |
$130.8K |
- |
| 2023-05-10 |
Goeddel David V |
10 Percent Owner |
RSU-Zuteilung |
78,407 |
$3.69 |
$289.32K |
78,407 |
| 2023-05-10 |
Rieflin William Jl |
Director |
RSU-Zuteilung |
78,407 |
$3.69 |
$289.32K |
78,407 |
| 2023-05-10 |
Perlmutter Roger M |
Director |
RSU-Zuteilung |
78,407 |
$3.69 |
$289.32K |
78,407 |
| 2023-05-10 |
Hooper Suzanne Sawochka |
Director |
RSU-Zuteilung |
78,407 |
$3.69 |
$289.32K |
78,407 |
| 2023-05-10 |
Guyer Shelly D |
Director |
RSU-Zuteilung |
78,407 |
$3.69 |
$289.32K |
78,407 |
| 2023-05-10 |
Ho Carole |
Director |
RSU-Zuteilung |
78,407 |
$3.69 |
$289.32K |
78,407 |
| 2023-03-02 |
Pierce Valerie L |
SVP, Gc & Cco |
RSU-Zuteilung |
49,000 |
- |
- |
55,667 |
| 2023-03-02 |
Lieu Hsiao D |
SVP, Chief Medical Officer |
RSU-Zuteilung |
53,000 |
- |
- |
55,605 |
| 2023-03-02 |
Woodhouse David J |
Chief Executive Officer |
RSU-Zuteilung |
127,200 |
- |
- |
144,854 |
| 2023-03-02 |
Chen Jin-long |
Chief Scientific Officer |
RSU-Zuteilung |
175,000 |
$4.36 |
$763K |
175,000 |
| 2023-03-02 |
Nolan Mangini Siobhan |
President and CFO |
RSU-Zuteilung |
76,000 |
- |
- |
76,000 |
| 2023-01-31 |
Goeddel David V |
10 Percent Owner |
Informierter Kauf |
176,730 |
$5.00 |
$883.4K |
927,231 |
| 2023-01-31 |
Column Group L P |
10 Percent Owner |
Informierter Kauf |
176,730 |
$5.00 |
$883.4K |
927,231 |
| 2023-01-30 |
Goeddel David V |
10 Percent Owner |
Informierter Kauf |
7,542 |
$5.00 |
$37.71K |
750,501 |
| 2023-01-30 |
Column Group L P |
10 Percent Owner |
Informierter Kauf |
7,542 |
$5.00 |
$37.71K |
750,501 |
| 2023-01-23 |
Goeddel David V |
Director |
Informierter Kauf |
9,900 |
$5.00 |
$49.49K |
742,959 |
| 2023-01-23 |
Column Group L P |
Director |
Informierter Kauf |
9,900 |
$5.00 |
$49.49K |
742,959 |
| 2023-01-20 |
Goeddel David V |
Director |
Informierter Kauf |
500 |
$5.00 |
$2.5K |
733,059 |
| 2023-01-20 |
Column Group L P |
Director |
Informierter Kauf |
500 |
$5.00 |
$2.5K |
733,059 |
| 2023-01-19 |
Goeddel David V |
Director |
Informierter Kauf |
37,639 |
$5.00 |
$188.1K |
732,559 |
| 2023-01-19 |
Column Group L P |
Director |
Informierter Kauf |
37,639 |
$5.00 |
$188.1K |
732,559 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
